Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
Pilot Feasibility Evaluation of a Mindfulness (Mindfulness) Intervention in Women Preparing for Chemotherapy for Breast Cancer
2 other identifiers
interventional
15
1 country
1
Brief Summary
This clinical trial tests how well a mindfulness intervention helps the prevention of chemotherapy-brain (chemo-brain) in women preparing for chemotherapy for breast cancer. Cognitive dysfunction after chemotherapy has been well-documented. Factors that have been used to document and/or have been correlated with chemo brain include self-report and structural brain changes including volume loss. Mindfulness is a type of meditation practice that can be learned to support well-being and decrease stress. Mindfulness is an approach that helps the person increase their awareness of the present moment without judgement. There are data that mindfulness may increase attention and concentration which may prevent some of the side effects from chemotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2023
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
January 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2025
CompletedDecember 8, 2025
December 1, 2025
1.8 years
January 12, 2024
December 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Participation rate
Will be determined by 75% of the participants will participate in at least 6 of the 8 mindfulness sessions.
Up to 1 year
Study Arms (1)
Supportive care (mindfulness program)
EXPERIMENTALPatients participate in a mindfulness program composed of topics that include mindfulness of breathing and the body scan, mindful eating, mindful activity, mindfulness in daily life, expanding the field of awareness, and maintaining a flexible mindfulness practice weekly over 2.5 hours for 8 weeks. Patients also undergo blood sample collection and fMRI on the study.
Interventions
Participate in mindfulness program
Undergo fMRI
Undergo blood sample collection
Eligibility Criteria
You may qualify if:
- years or older
- Breast cancer diagnosis preparing to undergo chemotherapy
You may not qualify if:
- Under the age of 18
- Cannot provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thomas Jefferson University Hopsital
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2024
First Posted
January 23, 2024
Study Start
November 13, 2023
Primary Completion
August 14, 2025
Study Completion
November 3, 2025
Last Updated
December 8, 2025
Record last verified: 2025-12